New Brain Cancer Treatment Shows Promise in Survival Boost

A new treatment combination significantly improved survival for patients with a deadly form of brain cancer. A clinical trial has found that using focused ultrasound to temporarily open the brain's protective barrier before chemotherapy leads to better outcomes for people with glioblastoma. Researchers from the University of Maryland School of Medicine conducted the study. They treated 34 patients with MRI-guided focused ultrasound and the chemotherapy drug Temozolomide. This group's results were then compared to 185 similar patients who received standard care. The technique uses ultrasound waves to create tiny openings in the blood-brain barrier. This barrier normally protects the brain but also blocks many drugs from entering. By opening it, more chemotherapy can reach the tumor. The trial results indicate this method is a promising step forward in treating glioblastoma. Further research is needed to confirm these findings and develop the technique for wider use.